103 related articles for article (PubMed ID: 22660309)
1. Biologics: Personalized drugs should cut care costs.
Malik NN
Nature; 2012 May; 485(7400):582. PubMed ID: 22660309
[No Abstract] [Full Text] [Related]
2. Era of personalized medicine may herald end of soaring cancer costs.
Keogh B
J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
[No Abstract] [Full Text] [Related]
3. Just caring: assessing the ethical and economic costs of personalized medicine.
Fleck LM
Urol Oncol; 2014 Feb; 32(2):202-6. PubMed ID: 24445288
[TBL] [Abstract][Full Text] [Related]
4. Personalized medicine: been there, done that, always needs work!
Murray JF
Am J Respir Crit Care Med; 2012 Jun; 185(12):1251-2. PubMed ID: 22707730
[No Abstract] [Full Text] [Related]
5. The right roadmap for personalized tests.
Bourzac K
Cancer Discov; 2012 Jun; 2(6):478. PubMed ID: 22684442
[No Abstract] [Full Text] [Related]
6. The future of medicine is very personal.
Shapiro SD
Am J Respir Crit Care Med; 2012 May; 185(9):903-4. PubMed ID: 22550204
[No Abstract] [Full Text] [Related]
7. Personalized medicine: medicine for the privileged?
Helft PR
Oncology (Williston Park); 2012 Sep; 26(9):814. PubMed ID: 23061334
[No Abstract] [Full Text] [Related]
8. Meeting the technical challenges of personalized medicine and companion diagnostics.
Montagna RA
MLO Med Lab Obs; 2012 Jan; 44(1):16, 18, 20 passim. PubMed ID: 22352180
[No Abstract] [Full Text] [Related]
9. The curse of dimensionality: a blessing to personalized medicine.
Catchpoole DR; Kennedy P; Skillicorn DB; Simoff S
J Clin Oncol; 2010 Dec; 28(34):e723-4; author reply e725. PubMed ID: 21041706
[No Abstract] [Full Text] [Related]
10. Whether it is personalized, precision, or mechanistic medicine--- the clinical laboratory has a role.
Kavsak PA
Clin Biochem; 2012 Apr; 45(6):384. PubMed ID: 22424084
[No Abstract] [Full Text] [Related]
11. 'Personalised medicine' through 'personalised medicines': time to integrate advanced, non-invasive imaging approaches and smart drug delivery systems.
Crommelin DJ; Storm G; Luijten P
Int J Pharm; 2011 Aug; 415(1-2):5-8. PubMed ID: 21320581
[TBL] [Abstract][Full Text] [Related]
12. Personalized medicine and therapeutic decision-making in oncology: a commentary on key environmental issues.
Freeman RA
J Oncol Pharm Pract; 2011 Sep; 17(3):295-7. PubMed ID: 20551112
[No Abstract] [Full Text] [Related]
13. Profiling protein expression and interactions: proximity ligation as a tool for personalized medicine.
Blokzijl A; Friedman M; Pontén F; Landegren U
J Intern Med; 2010 Sep; 268(3):232-45. PubMed ID: 20695973
[TBL] [Abstract][Full Text] [Related]
14. The role of nanobiotechnology in the development of personalized medicine.
Jain KK
Med Princ Pract; 2011; 20(1):1-3. PubMed ID: 21160206
[No Abstract] [Full Text] [Related]
15. Biosimilar versus generic drugs: same but different?
van de Vooren K; Curto A; Garattini L
Appl Health Econ Health Policy; 2015 Apr; 13(2):125-7. PubMed ID: 25652151
[No Abstract] [Full Text] [Related]
16. [Individualized medicine - our (lack of) understanding].
Windeler J
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):5-10. PubMed ID: 22325102
[TBL] [Abstract][Full Text] [Related]
17. Nanobiotechnology and personalized medicine.
Jain KK
Prog Mol Biol Transl Sci; 2011; 104():325-54. PubMed ID: 22093223
[TBL] [Abstract][Full Text] [Related]
18. A challenging drug development process in the era of personalized medicine.
Jørgensen JT
Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860
[TBL] [Abstract][Full Text] [Related]
19. Market watch: industry perspectives on personalized medicine.
Zuckerman R; Milne CP
Nat Rev Drug Discov; 2012 Mar; 11(3):178. PubMed ID: 22378258
[No Abstract] [Full Text] [Related]
20. The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.
Cloonan N; Waddell N; Grimmond SM
IDrugs; 2010 Nov; 13(11):778-81. PubMed ID: 21046525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
